Bank Of New York Mellon Corp Genocea Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $163 - $22,500	-16,305 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.06 - $2.82 $5,222 - $7,148	-2,535 Reduced 13.46%	16,305 $38,000
Q1 2021 May 13, 2021	SELL	$2.35 - $4.01 $3,351 - $5,718	-1,426 Reduced 7.04%	18,840 $51,000
Q1 2020 May 06, 2020	BUY	$1.26 - $2.73 $4,047 - $8,768	3,212 Added 18.83%	20,266 $34,000
Q2 2019 Aug 12, 2019	BUY	$3.47 - $6.71 $59,177 - $114,432	17,054 New	17,054 $67,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.